Search clinical trials for: exemestane (Aromasin®)
Total 14146 results
-
Actavis Inc.Withdrawn
-
PfizerTerminated
-
PfizerCompletedPost Menopausal Women With Early Breast Cancer
-
PfizerCompletedBreast NeoplasmsFrance
-
BiogenCompletedBreast CancerUnited States, Russian Federation, Australia, Belgium
-
PfizerCompleted
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
Jules Bordet InstituteNovartisCompleted
-
Roxane LaboratoriesCompletedBreast CancerUnited States
-
Roxane LaboratoriesCompleted
-
PfizerTerminated
-
PfizerCompletedBreast NeoplasmsChina
-
Roxane LaboratoriesCompleted
-
Inge Marie SvaneWithdrawn
-
PfizerCompletedBreast CancerKorea, Republic of
-
PfizerTerminatedInvasive Early Breast CancerRomania
-
Hellenic Breast Surgeons SocietyTerminated
-
SanofiActive, not recruitingBreast Cancer MetastaticKorea, Republic of, Belgium, Taiwan, China, France, United States, Argentina, Australia, Brazil, Canada, Czechia, Greece, Israel, Italy, Japan, Latvia, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey, Ukraine
-
Gilead SciencesCompletedSolid Tumors and LymphomasUnited States
-
Gilead SciencesTerminatedAdvanced Estrogen Receptor Positive HER2- Breast CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast CancerUnited States, Spain, Belgium, Canada, Italy, Ireland, United Kingdom
-
Chipscreen Biosciences, Ltd.Completed
-
University of Michigan Rogel Cancer CenterDamon Runyon Cancer Research FoundationCompletedPain | Breast Cancer | ArthralgiaUnited States
-
First Affiliated Hospital of Zhejiang UniversityRecruitingBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorChina
-
Centre Leon BerardRecruitingLow Grade Endometrial Stromal SarcomaFrance
-
Syndax PharmaceuticalsCompletedBreast Cancer | Estrogen Receptor Positive Breast CancerUnited States
-
PfizerCompletedBreast NeoplasmsBelgium, Brazil, United States, India, Peru, Philippines, Mexico, Canada, Colombia
-
PfizerCompleted
-
Finn, Olivera, PhDBreast Cancer Research Foundation; A Glimmer of Hope FoundationRecruitingDuctal Carcinoma in SituUnited States
-
AstraZenecaCompletedProgression-free SurvivalKorea, Republic of
-
Atossa Therapeutics, Inc.InClinRecruitingBreast Neoplasms | Invasive Breast Cancer | HER2-negative Breast Cancer | Estrogen-receptor-positive Breast CancerUnited States
-
Masonic Cancer Center, University of MinnesotaCompleted
-
M.D. Anderson Cancer CenterSusan G. Komen Breast Cancer FoundationCompleted
-
PfizerCompleted
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedBreast CancerUnited States
-
PfizerCompleted
-
Institut Claudius RegaudPHARMACIA SASCompleted
-
Nordic Society of Gynaecological Oncology - Clinical...Completed
-
National University Hospital, SingaporeUnknownBreast CarcinomaSingapore
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBreast Cancer | Hormone Receptor Positive TumorUnited States
-
Washington University School of MedicineGenomic Health®, Inc.RecruitingBreast Cancer | Breast Neoplasms | Cancer of Breast | Cancer of the BreastUnited States
-
University of Michigan Rogel Cancer CenterCompletedObesity | Breast Cancer | ArthralgiaUnited States
-
PfizerTerminatedBreast NeoplasmsSerbia, Croatia, Estonia
-
Organisation for Oncology and Translational ResearchUnknownHormone Receptor Positive Malignant Neoplasm of BreastChina
-
Veronica Morgan JonesRecruitingBreast Cancer | Breast Carcinoma | HER2-negative Breast Cancer | Node-negative Breast CancerUnited States
-
Ohio State University Comprehensive Cancer CenterPfizerCompletedBreast CancerUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merrimack PharmaceuticalsCompletedHer2 Negative Breast Cancer PatientsUnited States, Spain, Canada, Germany, Russian Federation
-
Institute of Cancer Research, United KingdomRecruitingBreast Cancer FemaleUnited Kingdom